Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children

Journal of Pediatric Urology

Volumn 3, Issue 6, 2007, Pages 438-442

  Hayashi, Atsushi ^a   Saito, Motoaki ^a   Okada, Shin ichi ^a   Hanada, Takuya ^a   Watanabe, Takeshi ^a   Satoh, Keisuke ^a   Kanzaki, Susumu ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Children; Hydroxypropylcellulose; Intravesical oxybutynin chloride; Neurogenic bladder

Indexed keywords

OXYBUTYNIN;

ANTICHOLINERGIC SYNDROME; ARTICLE; BLADDER CAPACITY; BLADDER COMPLIANCE; CASE REPORT; CYSTOMETRY; DETRUSOR DYSSYNERGIA; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MENINGOMYELOCELE; NEUROGENIC BLADDER; PRESCHOOL CHILD; PRIORITY JOURNAL; TERATOMA; URINARY TRACT INFECTION; URINE INCONTINENCE; VESICOURETERAL REFLUX;

EID: 35748982892     PISSN: 14775131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpurol.2007.05.007     Document Type: Article

References (17)

1. Massad C.A., Kogan B.A., and Trigo-Rocha F.E. The pharmacokinetics of intravesical and oral oxybutynin chloride. J Urol 148 (1992) 595-597
2. Buyse G., Waldeck K., Verpoorten C., Bjork H., Casaer P., and Andersson K.-E. Intravesical oxybutynin for neurogenic bladder dysfunction: less systematic side effects due to reduced first pass metabolism. J Urol 160 (1998) 892-896
3. Brendler C.B., Radebaugh L.C., and Mohler J.L. Topical oxybutynin chloride for relaxation of dysfunctional bladders. J Urol 141 (1989) 1350-1352
4. Greenfield S.P., and Fera M. The use of intravesical oxybutynin chloride in children with neurogenic bladder. J Urol 146 (1991) 532-534
5. Saito M., Tabuchi F., Otsubo K., and Miyagawa M. Treatment of overactive bladder with modified intravesical oxybutynin chloride. Neurourol Urodyn 19 (2000) 683-688
6. Saito M., Watanabe T., Tabuchi F., Otsubo K., Satoh K., and Miyagawa I. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience. Int J Urol 1 (2004) 592-596
7. Amark P., Bussman G., and Eksborg S. Follow-up of long time treatment with intravesical oxybutynin for neurogenic bladder children. Eur Urol 34 (1998) 148-153
8. Kasabian N.G., Vlachiotis J.D., Lais A., Klumpp B., Kelly M.D., Siroky M.B., et al. The use of intravesical oxybutynin chloride in patients with detrusor hyperactivity and detrusor hyperreflexia. J Urol 151 (1994) 944-945
9. Palmer L.S., Zebold K., Firlit C.F., and Kaplan W.E. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J Urol 157 (1997) 638-640
10. Reitz A., and Schurch B. Intravesical therapy options for neurogenic detrusor overactivity. Spinal Cord 42 (2004) 267-272
11. Yoshida M., Miyamae K., Iwashita H., Otani M., and Inadome A. Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging. Urology 63 (2004) 17-23
12. +)(i) in nociceptive neurons of rat dorsal root ganglia. J Neurophysiol 84 (2000) 1934-1941
13. Saito M., Kinoshita Y., Satoh I., Shinbori C., Suzuki H., Yamada M., et al. Ability of cyclohexenonic long-chain fatty alcohol to reverse diabetes induced cystopathy in the rats. Eur Urol 51 (2007) 479-488
14. Kim Y., Yoshimura N., Masuda H., de Miguel F., and Chancellor M.B. Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder afferent pathways. Urology 65 (2005) 238-242
15. Weese D.L., Roskamp D.A., Leach G.E., and Zimmern P.E. Intravesical oxybutynin chloride: experience with 42 patients. Urology 41 (1993) 527-530
16. Mizunaga M., Kaneko S., Miyata M., Taniguchi N., Iuchi H., Hashimoto H., et al. New intravesical oxybutynin hydrochloride used for the treatment of neurogenic bladder dysfunction. Neurourol Urodyn 15 (1996) 306-307
17. Ottolini M.C., Shaer C.M., Rushdon H.G., Majd M., Gonzales E.C., and Patel K.M. Relationship of asymptomatic bacteriuria and renal scarring in children with neurogenic bladders who are practicing clean intermittent self-catheterization. J Urol 157 (1995) 368-372